Haemophilus Influenzae Type B; Eagan, Titered (1 mL)
- Volume: 1.0mL
- Units/Pack: 1
- Storage Condition: -65°C or below
- Hazardous Information: Infectious
- Target: Does not apply
- Product Type: Live Organism
For Research Use Only. Not for use in Diagnostic Procedures.MTA Required
Purchase of this live material requires submittal of an executed ZeptoMetrix MTA prior to shipment.Hawaii Permit
Import Permit for the State of Hawaii If importing a product into the U.S. State of Hawaii, it is suggested that the purchaser contact the Hawaiian Department of Agriculture to determine if a permit is required for such import. More information can be found here: Hawaii Department of Agriculture (HDOA), Plant Industry Division, Plant Quarantine Branch
Each frozen aliquot contains 1 mL of a pure, titered culture of Haemophilus influenzae type b, Eagan. The identification of this organism was confirmed by 16S sequencing. The purity of the culture was monitored by Gram staining and by additional culturing. The titer was performed on one aliquot after freezing. The freezing medium contains 15% glycerol as a cryoprotectant. Please see the Certificate of Analysis for the specific freezing medium used.
• Organism identification confirmed by 16S sequencing
• Live organism BSL 1
• MTA required
• Store at -65°C or below
• 1 mL pure, titered culture
For Research Use Only. Not for use in diagnostic procedures. Infectious, titered microorganisms can be utilized for analytical testing during assay development, including limit of detection (LOD) and cross-reactivity studies. When used as a control for nucleic acid tests, the same protocols as those used to extract and amplify clinical specimens should be employed.
These products are NOT intended for use in the manufacture or processing of injectable products subject to licensure under section 351 of the Public Health Service Act or for any other product intended for administration to humans. Propagation or commercialization are prohibited without prior written consent from Antylia Scientific.
When used as a control for nucleic acid tests, the same protocols as those used to amplify extracted clinical specimens should be employed.
The suitability and performance characteristics should be determined by your laboratory for each intended usage.